or Try an Advanced Search...

    Hepatitis B Virus Stocks List

    Symbol Grade Name % Change
    IONS B Ionis Pharmaceuticals, Inc. -1.15
    ABUS B Arbutus Biopharma Corporation 0.97
    INO D Inovio Pharmaceuticals, Inc. 6.56
    NNVC D NanoViricides, Inc. 7.56
    NTLA D Intellia Therapeutics, Inc. 0.40
    VIR F Vir Biotechnology, Inc. 2.25
    HOOK F HOOKIPA Pharma Inc. 6.17
    BMY F Bristol-Myers Squibb Company -0.55
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection

    Related ETFs - A few ETFs which own one or more of the above listed Hepatitis B Virus stocks.

    Symbol Grade Name Weight
    ARKG F ARK Genomic Revolution Multi-Sector ETF 8.83
    FTXH B First Trust Nasdaq Pharmaceuticals ETF 6.5
    GNOM C Global X Genomics & Biotechnology ETF 6.06
    PPH A Market Vectors Pharmaceutical ETF 4.49
    IHE B iShares U.S. Pharmaceutical ETF 4.4
    View all Hepatitis B Virus ETFs...
    Compare ETFs
    Compare ARKG to IHE Compare FTXH to PPH Compare GNOM to PPH

        Hepatitis B Virus Stocks Recent News

        Date Stock Title
        Jul 1 BMY What the Options Market Tells Us About Bristol-Myers Squibb
        Jul 1 BMY Bristol-Myers Squibb to Pay $2.7 Million to Settle Potential Anti-Competition Case, Israeli Agency Says
        Jul 1 INO Inovio Pharmaceuticals added to Russell 2000 index effective July 1
        Jul 1 BMY Bristol Myers to pay $2.7 million to settle Israel anti-competition charges
        Jul 1 INO INOVIO Added to Russell 2000® Index Effective July 1, 2024
        Jul 1 BMY Eisai and Bristol Myers cancel cancer ADC deal
        Jun 28 BMY Bristol-Myers Squibb: Time To Double Down
        Jun 27 BMY Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
        Jun 27 NTLA Intellia (NTLA) Shares Fall as CFO Glenn Goddard Steps Down
        Jun 27 NTLA Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
        Jun 26 IONS FDA Accepts Ionis' (IONS) NDA for Rare Disease Drug Olezarsen
        Jun 26 VIR Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection
        Jun 26 NTLA Intellia Therapeutics appoints CFO
        Jun 26 NTLA Intellia Therapeutics Announces CFO Transition
        Jun 26 NTLA First-of-its-kind Intellia data suggest CRISPR drug could be given more than once
        Jun 25 BMY Bristol Myers Squibb (BMY) Stock Declines While Market Improves: Some Information for Investors
        Jun 25 IONS Ionis gains as anti-lipid therapy undergoes FDA priority review
        Jun 25 NTLA Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform
        Jun 25 NTLA 3 Gene Editing Stocks That Could Make Your Grandchildren Rich
        Jun 25 IONS Ionis announces olezarsen FCS New Drug Application accepted for Priority Review and enrollment in Phase 3 sHTG program completed
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Hepatitis B Immunodeficiency Infectious Diseases Hepatitis C Hepatitis C Virus Amyloid Amyloidosis Biopharmaceutical Biotechnology Cancer Coronavirus Influenza Medicine Alcohol Cholesterol Diabetes Dystrophy Ebola Genetics Hepatitis C Virus Infection
        Hepatitis B Virus

        Hepatitis B virus (HBV), is a partially double-stranded DNA virus, a species of the genus Orthohepadnavirus and a member of the Hepadnaviridae family of viruses. This virus causes the disease hepatitis B.

        More about Hepatitis B Virus
        Browse All Tags